Use of Bone-Modifying Agents in Myeloma and Bone Metastases

Faculty from the Hematology and Oncology Division, led by Erica Campagnaro, MD, Associate Professor of Internal Medicine, review the new data on dosing of bone-modifying agents and how it influences their clinical practice.